Akbay Erdem, Çayan Selahittin, Kılınç Celal, Bozlu Murat, Tek Mesut, Efesoy Ozan
Department of Urology, Mersin University School of Medicine, Mersin, Turkey.
Department of Urology, Mersin City Hospital, Mersin, Turkey.
Turk J Urol. 2018 Dec 20;45(2):129-134. doi: 10.5152/tud.2018.35920. Print 2019 Mar.
The aim of the study was to evaluate the short term efficacy of intravesical instillation of hyaluronic acid in patients with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC).
The study included 54 women with BPS/IC who received intravesical instillation of hyaluronic acid treatment (120 mg/50 mL) for 6 weeks. Visual Analogue Scale (VAS), The O'Leary Sant Questionnaire (ICSI/ICPI) forms of the patients were filled by the clinician and the health technician separately before and 3 months after the treatment. Demographic characteristics of the patients were recorded, and effectiveness of the treatment was investigated according to these data.
Decrease in mean VAS and mean total scores of ICSI and ICPI was observed after three months of intravesical instillation of hyaluronic acid treatment (55%, p<0.05 and 48.5%, p<0.05 and 45.5%, p<0.05, respectively). In most of the patients, all scores of VAS, ICSI and ICPI improved (minimum: 75.9%, maximum: 94.4%). Mostly the symptoms of nocturia and pollakiuria were seen, and treated after the instillation treatment.
It has been observed that in the short-term follow-up of intravesical instillation of hyaluronic acid treatment, the symptoms have highly improved. Also, Turkish versions of ICSI and ICPI forms were reliable and comprehensible.
本研究旨在评估膀胱内灌注透明质酸对膀胱疼痛综合征/间质性膀胱炎(BPS/IC)患者的短期疗效。
本研究纳入了54例BPS/IC女性患者,她们接受了为期6周的膀胱内透明质酸灌注治疗(120mg/50mL)。临床医生和健康技术人员分别在治疗前和治疗后3个月填写患者的视觉模拟量表(VAS)、奥利里-桑特问卷(ICSI/ICPI)。记录患者的人口统计学特征,并根据这些数据研究治疗效果。
膀胱内灌注透明质酸治疗3个月后,观察到VAS平均得分以及ICSI和ICPI平均总分均有所下降(分别为55%,p<0.05;48.5%,p<0.05;45.5%,p<0.05)。大多数患者的VAS、ICSI和ICPI所有得分均有所改善(最低:75.9%,最高:94.4%)。最常见的症状是夜尿症和尿频,在灌注治疗后得到了治疗。
观察发现,在膀胱内灌注透明质酸治疗的短期随访中,症状有显著改善。此外,ICSI和ICPI表格的土耳其语版本可靠且易于理解。